Drug Shortage Report for PROPOFOL INJECTION
Report ID | 43857 |
Drug Identification Number | 02244379 |
Brand name | PMS-PROPOFOL |
Common or Proper name | PROPOFOL |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | PROPOFOL |
Strength(s) | 10MG |
Dosage form(s) | EMULSION |
Route of administration | INTRAVENOUS |
Packaging size | 50ML & 100ML |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-04-01 |
Actual start date | 2018-04-05 |
Estimated end date | Unknown |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | Product to be discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2020-06-10 | French | Compare |
v11 | 2020-06-10 | English | Compare |
v10 | 2018-06-27 | French | Compare |
v9 | 2018-06-27 | English | Compare |
v8 | 2018-04-06 | French | Compare |
v7 | 2018-04-06 | English | Compare |
v6 | 2018-04-06 | English | Compare |
v5 | 2018-04-06 | French | Compare |
v4 | 2018-04-06 | English | Compare |
v3 | 2018-04-02 | English | Compare |
v2 | 2018-03-23 | French | Compare |
v1 | 2018-03-23 | English | Compare |
Showing 1 to 12 of 12